Geller JL, Adams JS. Reply to: Increase in Bone Mass after Vitamin D Replacement: Can We Ignore Regression to the Mean? Endocr Pract. 2008;14;5
Geller JL, Adams JS. Vitamin D Therapy. Current Osteoporosis Reports 2008 Mar;6 (1):5-11.
Cooper OB, Geller JL and Melmed S. Ovarian Hyperstimulation Syndrome caused by an FSH-Secreting Pituitary Adenoma. Nat Clin Pract Endocrinol Metab. Feb 12, 2008
Geller JL, Hu B, Reed S, Mirocha J and Adams JS. Repair of Vitamin D Insufficiency Increases Bone Mass in Bisphosphonate-Treated Patients. Endo Prac. 2008; 14:3
Geller JL Vitamin D: The Sunshine Hormone. Food Technology, June 2007
Geller JL, Adams, JS. Proton Pump Inhibitor Therapy and Hip Fracture Risk. JAMA. 2007; 297:1429
Geller JL, Azarmindokht K, Kelly MH, et al. Clinical Vignette: Cinacalcet in the Management of Tumor-Induced Osteomalacia. J Bone Min Res. 2007; Mar 12
Geller JL The Way I see it: Healthcare Reform Begins with Patient. Medical Economics. Dec 15, 2006
Karakelides H, Geller JL, Schroeter AL, Chen H, Behn PS, Adams JA, Hewison M, Wermers RA. Vitamin D-mediated hypercalcemia in slack skin disease: further evidence for extra-renal expression of 25-hydroxyvitamin D-1?-hydroxylase in granulomatous disorders. J Bone Min Res. 2006 Sep; 1496-9
Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented Adrenocrotical Carcinoma:case report and review. Endocr Pathol. 2006; 17: 297-304.
Geller JL, Braunstein GB. Dermatological Manifestations of Hypopituitarism. Clinics in Dermatology. 2006; 42:266-275.
Geller JL. Borrowing Against the Bones: The Price of Eucalcemia. Nutrition and the M.D. 2006; 32:5
Geller JL, Adams JS. Statins and Fracture: All Variables Accounted For? Archives of Internal Medicine 2006; 166:1041
Geller JL, Arteaga V, Fan X, Yu J. A Symptomatic Prolactinoma Co-existing within a Rathke’s Cleft Cyst Invading Bone: Case Report and Review. Endocrinol 2006;91-94.
Geller, JL, Mertens, RB and Weiss LM. Adrenocortical Carcinoma: Many Questions Remain Unanswered. The Endocrinologist, 2005; 15: 309-312.
Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Targan SR. Treatment with Infliximab is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease. Journal of Clinical Gastroenterology, 2006; 40:55-63.
Geller JL, Hackner D. Prolonged Refractory Streptococcal Toxic Shock Syndrome Complicated by Pulmonary Thromboemboli: Case Report and Review. Annals of Hematology. 2005 Apr 7
Bhushan V, Pall V, Le T, Yen YM, Geller JL, Gupta S. Clinical Science Color Atlas. Blackwell, 2002
Geller JL, Reed, S, Mirocha J, Adams JS. Vitamin D Insufficiency and Unresponsiveness to Bisphosphonates. Cleveland Clinic Bone Innovation Summit, May 5, 2006.
JL. Geller, C. Cutler, M. H. Kelly, J. S. Adams, M. T. Collins. Cinacalcet Is Associated with Decreased Serum FGF-23 and Improved Phosphorous Homeostasis in Patients with Tumor-Induced Osteomalacia. The 27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, Tennessee, 2005.
Wermers RA, Karakelides H, Adams JS, Chen H, Geller JL, Hewison M. Vitamin D-Mediated Hypercalcemia in Granulomatous Slack Skin Disease: Evidence for the Extra-renal 1-Hydroxylation of 25-hydroxvitamin D in Involved Skin Granulomata. Endocrine Society 87th Annual Meeting, San Diego, 2005
Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented Adrenocortical Carcinoma. Endocrine Society 87th Annual Meeting, San Diego, 2005
Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Targan SR. Treatment with Infliximab is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease. American Society for Bone and Mineral Research, 26th Annual Meeting, Seattle, WA, 2004
Lectures and Seminars
The Spectrum of Primary Hyperparathyroidism. Cedars-Sinai Thyroid Disease Symposium, March 15, 2009
Osteoporosis: Not Just Your Grandmother’s Disease. Cedar's-Sinai Center for International Health & Telemedicine. January 29, 2009
Osteoporosis Myths. Tarzana Medical Center Calcium Metabolism Symposium. November 11, 2008
Common Endocrine Issues in the Hospitalized Patient. Society for Hospital Medicine April 5, 2008
Key Concepts in Bone Mineral Densitometry Cedars-Sinai Medical Center, Feb 28, 2008
Exploiting the Calcium-Sensing Receptor in the Management of Hypophosphatemic Osteomalacia. Harbor UCLA Endocrine Clinical Conference, November 7, 2007
The Top 10 Vitamin D Myths. West Los Angeles VA Hospital Endocrine Grand Rounds, Sept 28, 2007
A Fast Acting Goiter. Cedars-Sinai Thyroid Cancer Center Multidisciplinary Conference June 28, 2007
Osteoporosis Myths, Legends, Rumors and Lies. Cedars-Sinai Medical Grand Rounds, June 1, 2007
Hyperparathyroidism and Beyond: Expanding the Role of Calcium-Sensing Receptor Suppression. Cedars-Sinai Medical Center Endocrine Grand rounds, Feb 13, 2000
Vitamin D Dysregulation Cedars-Sinai Medical Center Internal Medicine Grand rounds, January 11, 2007.
Gonadotropin Secreting Pituitary Adenoma with Ovarian Hyperstimulation. Cedars-Sinai Pituitary Center Interdisciplinary Pituitary Case Conference, November 28, 2006.
American Board of Internal Medicine Endocrinology Review. Cedars-Sinai Medical Center, June 19, 2006.
The Association of Vitamin D Insufficiency with a Declining Response to Bisphosphonates. Cleveland Clinic Bone Innovation Summit. May 4, 2006.
Principles of Bone Densitometry. Cedars-Sinai Endocrinology Teaching Seminar, May 1, 2006.
Familial Nonmedullary Thyroid Carcinoma. Cedars-Sinai Medical Center Thyroid Cancer Grand Rounds, January 26, 2006.
Metastatic Pheochromocytoma: Management. Cedars-Sinai Medical Center Carcinoid and Neuroendocrine Tumor Center Interdisciplinary Conference, November 15, 2005.
Cinacalcet in the Management of FGF-23-Mediated Hypophosphatemia. American Society for Bone and Mineral Research, Bone and Mineral Working Group, September 26, 2005
Metastatic Pheochromocytoma: Clinical Presentation. Cedars-Sinai Medical Center Carcinoid and Neuroendocrine Tumor Center Interdisciplinary Conference, July 21, 2005.
What is “Off-Label?” UCLA K30 Journal Club, June 14th, 2005.
American Board of Internal Medicine Endocrinology Review. Cedars-Sinai Medical Center, May 30, 2005.
A Case of an Invasive Prolactinoma. Cedars-Sinai Pituitary Center Interdisciplinary Pituitary Case Conference, March 29, 2005.
Prolactinoma within a Rathke’s Cleft Cyst Invading Bone. Cedars-Sinai Pituitary Center Interdisciplinary Pituitary Case Conference, February 1, 2005.
Metabolic Bone Disease. Cedars-Sinai Medical Center, Medicine Grand Rounds, December 21, 2004.
Effect of Oral Alendronate on Bone Mineral Density. UCLA K30 Journal Club July 16, 2004.